Slagelse Hospital

Running trials

• Recruiting

  A Phase III Study to Evaluate the Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity

  NCT07843498· Phase 3· Source

• Not yet recruiting

  BEAT Fatigue

  2024-519268-41-00· Phase 4· Source

• Recruiting

  A study to measure mirikizumab levels in breast milk of lactating participants receiving mirikizumab therapeutically for an approved indication

  2025-522362-78-00· Phase 4· Source

• Recruiting

  Comparing Hydrocortisone and Prednisolone for Acute Exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD)

  NCT06892210· Phase 4· Source

• Recruiting

  EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

  NCT07064473· Phase 3· Source

• Recruiting

  A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart

  NCT06935370· Phase 3· Source

• Recruiting

  Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin

  NCT06677060· Phase 3· Source

• Recruiting

  A Pragmatic Trial Comparing Empagliflozin and Dapagliflozin Through Cluster Randomization Embedded in the Electronic Health Record

  NCT06642272· Phase 4· Source

• Recruiting

  What Influence Re-participation in the Danish Colorectal Screening Program.

  NCT07353632· Source

• Active, not recruiting

  DAPHNE

  2024-510746-14-00· Phase 4· Source

• Recruiting

  DECONGEST-AHF: Vasodilatation or Loop Diuretics in Acute Heart Failure

  NCT05276219· Phase 4· Source

• Active, not recruiting

  A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation

  NCT05757869· Phase 3· Source

• Active, not recruiting

  The Danish Non-vitamin K Antagonist Oral Anticoagulation Study in Patients With Atrial Fibrillation

  NCT03129490· Phase 4· Source

• Enrolling by invitation

  CMR in T2DM: The NSR Cohort

  NCT05915260· Source

• Recruiting

  INVITED trial

  2022-500906-17-01· Phase 2· Source

• Recruiting

  INfluenza VaccInation To Mitigate typE 1 Diabetes

  NCT05585983· Phase 4· Source

• Not yet recruiting

  Effects of Intravenous Administered Iron in Non-anemic Iron Deficient Patients With Colorectal Cancer

  NCT05220800· Phase 2· Source

• Recruiting

  Diabetic Nephropathy in People With Diabetes. Prevalence and Predictive Factors

  NCT04916132· Source

• Active, not recruiting

  The CROCO Study: CROhn's Disease COhort Study

  NCT05420233· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Heart failure4 recruiting
• Type 2 diabetes4 recruiting
• Chronic kidney disease2 recruiting
• Colorectal cancer2 recruiting
• Type 1 diabetes2 recruiting
• COPD1 recruiting
• Crohn's disease1 recruiting
• High blood pressure1 recruiting
• Obesity1 recruiting
• Rheumatoid arthritis1 recruiting
• Ulcerative colitis1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  A proof of concept and dose-finding study of XXB750 in patients with heart failure

  2023-504678-39-00· Phase 2· Source

• Completed

  Intratumoral Flu Vaccine and Pembrolizumab in Colorectal Cancer

  2023-503228-17-00· Phase 2· Source

• Completed

  A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome

  NCT05754957· Phase 3· Source

• Completed

  A Study of Population and Sex-specific Troponin Cutoffs for Ruling Out Acute Myocardial Infarction

  NCT05336435· Source

• Active, not recruiting

  Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) (REMODEL-1)

  NCT05147220· Phase 3· Source

• Completed

  A Study of Vericiguat (MK-1242) in Participants With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-035)

  NCT05093933· Phase 3· Source

• Completed

  Personalized Exercise Therapy and Self-management Support for Patients With Multimorbidity

  NCT04645732· Source

• Completed

  EMPACT-MI: A Study to Test Whether Empagliflozin Can Lower the Risk of Heart Failure and Death in People Who Had a Heart Attack (Myocardial Infarction)

  NCT04509674· Phase 3· Source

• Completed

  DANHEART (H-HeFT and Met-HeFT)

  NCT03514108· Phase 4· Source

Trial sites

• Department of Cardiology and Endocrinology, Slagelse Hospital1 trial
• Slagelse Hospital20 trials
• Slagelse Hospital, department of cardiology and endocrinology, medicine 21 trial
• Slagelse Sygehus6 trials